Search research articles
Contact Us
Filters
Showing results (721-730 of 3,556) with videos related to
Page
of 356
Sort By:
Behavior Therapy
|
August 20, 2019
Goal Achievement and Goal-Related Cognitions in Behavioral Activation Treatment for Depression
Keegan Knittle, Paul Gellert, Clair Moore, et al.
Transfusion
|
May 1, 1992
In vitro and in vivo evaluation of cotton wool filtration of platelet concentrates obtained by automated and manual apheresis
S Holme, E Snyder, A Heaton, et al.
Cellular Immunology
|
October 15, 1990
IL4 is not required for proliferative responses in B cells stimulated by anti-IgD-dextran conjugates even under limiting conditions of cell-cell interaction
M L Lindsberg, M Brunswick, A Keegan, et al.
Current Opinion in Genetics & Development
|
March 30, 2025
To splice or not to splice: pseudoexons in neurological disease and opportunities for intervention
Sue Fletcher, Niall P Keegan, Rita Mejzini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2002
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
Moises Perez-G, Marco Melo, Achsah D Keegan, et al.
Analytical Chemistry
|
October 15, 2009
Application of lead and strontium isotope ratio measurements for the origin assessment of uranium ore concentrates
Zsolt Varga, Maria Wallenius, Klaus Mayer, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
July 21, 2016
Predicting which patients actually receive radiation following breast conserving therapy in Canadian populations
Keegan Guidolin, Michael Lock, Lucie Richard, et al.
British Journal of Biomedical Science
|
April 21, 2007
Human papillomavirus prevalence and genotypes in an opportunistically screened Irish female population
H Keegan, F Ryan, A Malkin, et al.
The Oncologist
|
November 10, 2009
FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme
Martin H Cohen, Yuan Li Shen, Patricia Keegan, et al.
The Oncologist
|
March 14, 2009
FDA review of a panitumumab (Vectibix) clinical trial for first-line treatment of metastatic colorectal cancer
Ruthann M Giusti, Martin H Cohen, Patricia Keegan, et al.
Page
of 356
Search research articles
Search
Showing results (721-730 of 3,556) with videos related to
Sort By:
Page
of 356
Behavior Therapy
|
August 20, 2019
Goal Achievement and Goal-Related Cognitions in Behavioral Activation Treatment for Depression
Keegan Knittle, Paul Gellert, Clair Moore, et al.
Transfusion
|
May 1, 1992
In vitro and in vivo evaluation of cotton wool filtration of platelet concentrates obtained by automated and manual apheresis
S Holme, E Snyder, A Heaton, et al.
Cellular Immunology
|
October 15, 1990
IL4 is not required for proliferative responses in B cells stimulated by anti-IgD-dextran conjugates even under limiting conditions of cell-cell interaction
M L Lindsberg, M Brunswick, A Keegan, et al.
Current Opinion in Genetics & Development
|
March 30, 2025
To splice or not to splice: pseudoexons in neurological disease and opportunities for intervention
Sue Fletcher, Niall P Keegan, Rita Mejzini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2002
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
Moises Perez-G, Marco Melo, Achsah D Keegan, et al.
Analytical Chemistry
|
October 15, 2009
Application of lead and strontium isotope ratio measurements for the origin assessment of uranium ore concentrates
Zsolt Varga, Maria Wallenius, Klaus Mayer, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
July 21, 2016
Predicting which patients actually receive radiation following breast conserving therapy in Canadian populations
Keegan Guidolin, Michael Lock, Lucie Richard, et al.
British Journal of Biomedical Science
|
April 21, 2007
Human papillomavirus prevalence and genotypes in an opportunistically screened Irish female population
H Keegan, F Ryan, A Malkin, et al.
The Oncologist
|
November 10, 2009
FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme
Martin H Cohen, Yuan Li Shen, Patricia Keegan, et al.
The Oncologist
|
March 14, 2009
FDA review of a panitumumab (Vectibix) clinical trial for first-line treatment of metastatic colorectal cancer
Ruthann M Giusti, Martin H Cohen, Patricia Keegan, et al.
Page
of 356